AMN Healthcare Q2 2026 Earnings Call Summary

1Key Financial Results and Metrics:

Consolidated Revenue: $673 million, a 2% increase year-over-year and 6% above guidance.

Adjusted EBITDA: $73 million (10.9% of revenue), up 26% year-over-year.

Adjusted EPS: $0.77 compared to $0.30 in the same quarter last year.

Net Income: $21 million, a significant recovery from a net loss of $116 million in Q2 2025.

Cash Position: Ended the quarter with $362 million in cash, exceeding expectations.

Debt: Total debt of $750 million, with a leverage ratio of 1.5x.

2Strategic Updates and Business Highlights:

Segment Performance:

Nurse and Allied Solutions: Revenue of $422 million, up 11% year-over-year; strong demand in travel nursing and allied services.

Physician and Leadership Solutions: Revenue of $165 million, down 6% year-over-year; notable growth in the search business (27% year-over-year).

Technology and Workforce Solutions: Revenue of $87 million, down 15% year-over-year; pricing pressures noted.

Acquisitions: Completed two strategic acquisitions to enhance capabilities, including Jaide Health for language services and ESSENTIAL Brand Leadership Assessment.

Market Position: AMN is leveraging its leadership in total talent solutions to respond to increasing demand for flexible labor and workforce optimization.

3Forward Guidance and Outlook:

Third Quarter Revenue Guidance: Expected to be between $640 million and $655 million.

Nurse and Allied Segment Growth: Anticipated to grow 9% to 11% year-over-year.

Physician and Leadership Solutions: Projected revenue decline of 5% to 7% year-over-year.

Technology and Workforce Solutions: Expected to decline 11% to 13% year-over-year.

EBITDA Margin Guidance: Projected to be between 6.5% and 7%.

4Bad News, Challenges, or Points of Concern:

Declining Segments: Physician and Leadership Solutions and Technology and Workforce Solutions are experiencing revenue declines.

Labor Market Dynamics: While demand is increasing, contingent labor rates remain historically low, impacting pricing power.

Visa Processing Delays: International nurse growth may be hindered by delays in visa appointments, affecting future revenue expectations.

Competitive Pressures: Increased competition in the staffing market could impact pricing and margins.

5Notable Q&A Insights:

Contingent Labor Utilization: Current contingent labor utilization is at mid- to high single digits, down from pre-COVID levels but still below historical norms.

Demand Drivers: Demand for nurses and allied health professionals is broad-based across various healthcare settings, with significant growth in travel nursing orders.

Pricing Trends: Although demand is increasing, bill rates have remained stable, with expectations for potential increases if demand persists.

Kaiser RFP Process: AMN is positioned well for the upcoming RFP process with Kaiser, but competitive pressures may lead to negotiations for better terms.

Future Growth: The company is optimistic about returning to growth in the locum tenens segment by 2027, driven by ongoing transformation efforts. This summary encapsulates the key points from AMN Healthcare's Q2 2026 earnings call, highlighting both the successes and challenges faced by the company.